Sutherland D E, Najarian J S, Greenberg B Z, Senske B J, Anderson G E, Francis R S, Goetz F C
Ann Intern Med. 1981 Nov;95(5):537-41. doi: 10.7326/0003-4819-95-5-537.
A new modification of pancreas transplant technique, the vascularized segmental intraperitoneal graft without duct ligation, has provided reversal of insulin-dependent (type I) diabetes mellitus for as long as 2 years of comfortable life. Although the risks associated with immunosuppression remain high (two of the 12 patients have died of early postoperative infection), selected data are presented from six cases to show the following striking hormonal and metabolic results after transplantation and withdrawal of insulin: restoration of normal beta cell function as shown by 24-hour urine C-peptide excretion and acutely responsive serum insulin, restoration of normal suppressibility of plasma glucagon, elimination of ketosis and negative nitrogen balance, normal fasting plasma glucose and glycosylated hemoglobin, and normal or near-normal glucose tolerance. These results provide a standard for current explorations of new ways of treating insulin-dependent diabetes.
一种胰腺移植技术的新改良方法,即不结扎导管的血管化节段性腹腔内移植,已使胰岛素依赖型(I型)糖尿病患者逆转,过上了长达两年的舒适生活。尽管免疫抑制相关风险仍然很高(12例患者中有2例死于术后早期感染),但现提供6例患者的部分数据,以展示移植及停用胰岛素后以下显著的激素和代谢结果:24小时尿C肽排泄及急性反应性血清胰岛素表明β细胞功能恢复正常;血浆胰高血糖素抑制能力恢复正常;酮症和负氮平衡消除;空腹血浆葡萄糖和糖化血红蛋白正常;葡萄糖耐量正常或接近正常。这些结果为当前探索治疗胰岛素依赖型糖尿病的新方法提供了一个标准。